LIPELLA PHARMACEUTICALS INC. - Common Stock (LIPO)

CUSIP: 53630L100

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
1,231,122
Total 13F shares
370,013
Share change
+330,373
Total reported value
$377,412
Price per share
$1.02
Number of holders
7
Value change
+$336,980
Number of buys
6

Quarterly Holders Quick Answers

What is CUSIP 53630L100?
CUSIP 53630L100 identifies LIPO - LIPELLA PHARMACEUTICALS INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LIPELLA PHARMACEUTICALS INC. - Common Stock (LIPO) as of Q4 2023

As of 31 Dec 2023, LIPELLA PHARMACEUTICALS INC. - Common Stock (LIPO) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 370,013 shares. The largest 7 holders included SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, Tower Research Capital LLC (TRC), UBS Group AG, and WELLS FARGO & COMPANY/MN. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.